Key Benefits & Features: Supports healthy fat metabolism Enhances exercise performance Supports post-exercise recovery Helps maintain energy and muscle function Research-backed 2-gram daily dose Stimulant- and caffeine-free Each daily serving provides a full 2 grams to help your body transport fat into cells where it can be used for energy, while also supporting reduced muscle soreness and faster recovery after training

Key Points The incidence of nonmelanoma skin cancer (NMSC) continues to increase, and it is estimated that 20% of Americans will develop this type of cancer during their lifetime The 'gold standard' for treating NMSC is Mohs micrographic surgery, although other surgical modalities such as excision or curettage and electrodesiccation are often very effective, less expensive, and can be the treatment of choice in certain circumstances Radiation therapy is an effective treatment option, although side effects of this method and the cost limit its usefulness to cases involving nonsurgical candidates Newer immune-modulating agents such as imiquimod have proven effective for treating superficial variants of NMSC and can be used in instances when other methods would be difficult to perform or where cosmesis is important Photodynamic therapy is an emerging treatment for superficial NMSC, although it should not be used for thicker tumors This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Petruzziello C, Saviano A, Manetti LL, Macerola N, Ojetti V (2024) The role of gut microbiota and the potential effects of probiotics in heart failure
The absolute weight loss associated with semaglutide use is up to 4.6 kg and 6.5 kg at doses of 0.5 mg and 1.0 mg respectively over 40 weeks
( G ) LDH release into coronary effluents from perfused WT mouse hearts, measured by ELISA at timed intervals between 10 and 40 minutes of reperfusion and normalized to coronary flow (mL/min/g heart weight) ( n = 3)